Medical Developments (Australia) Today
| MVP Stock | 0.42 0.01 2.33% |
Performance0 of 100
| Odds Of DistressLess than 24
|
Medical Developments is selling for under 0.42 as of the 26th of November 2024; that is 2.33 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.42. Medical Developments has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Medical Developments International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Medical Developments is entity of Australia. It is traded as Stock on AU exchange. The company has 112.66 M outstanding shares. More on Medical Developments International
Moving against Medical Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Medical Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medical Developments' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medical Developments or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Medical Developments' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Medical Developments' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMedical Developments can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medical Developments' financial leverage. It provides some insight into what part of Medical Developments' total assets is financed by creditors.
| |||||
Medical Developments International (MVP) is traded on Australian Securities Exchange in Australia and employs 9 people. Medical Developments is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medical Developments's market, we take the total number of its shares issued and multiply it by Medical Developments's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medical Developments operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 112.66 M outstanding shares.
Medical Developments International has accumulated about 24.66 M in cash with (10.78 M) of positive cash flow from operations.
Check Medical Developments Probability Of Bankruptcy
Ownership AllocationMedical Developments maintains a total of 112.66 Million outstanding shares. Medical Developments International secures significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Medical Developments stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medical Ownership Details
Medical Developments Risk Profiles
Although Medical Developments' alpha and beta are two of the key measurements used to evaluate Medical Developments' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.18 | |||
| Standard Deviation | 3.31 | |||
| Variance | 10.99 | |||
| Risk Adjusted Performance | (0.02) |
Medical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medical Developments without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Medical Developments Corporate Management
Elected by the shareholders, the Medical Developments' board of directors comprises two types of representatives: Medical Developments inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Developments' management team and ensure that shareholders' interests are well served. Medical Developments' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Developments' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wayne Pearce | Head Production | Profile | |
| Brent MacGregor | Chief Officer | Profile | |
| Wai Chi | Head Affairs | Profile | |
| Stefaan Schatteman | Head Europe | Profile | |
| Anita James | Chief Officer | Profile | |
| Greer Lucas | Head Culture | Profile | |
| Tara Eaton | General Secretary | Profile |
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.